STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #4086 by analyst upside · 2026-06-27
MEDP
Medpace Holdings, Inc.
Healthcare · Market Cap $15B · P/E 33.1x
ANALYST PRICE TARGET
-15.9%
implied upside to consensus target
Current Price $527.07
Consensus Target $443.5
Bull Target $495.0
Bear Target $329.0
Analysts Covering 12
ANALYST CONSENSUS - HOLD
Strong Buy
1
Buy
3
Hold
7
Sell
1
52-Week Low $306.7
52-Week High $628.92
YTD Return -7.7%
FUNDAMENTALS
Market Cap $15B
P/E Ratio (TTM) 33.1x
Forward P/E 28.1x
EPS (TTM) $15.91
PEG Ratio 3.15
Dividend Yield N/A
Revenue (TTM) $2.7B
Profit Margin 17.2%
52-WEEK RANGE
52-Week Low $306.7
52-Week High $628.92
Current Price $527.07
Bear Target $329.0
Bull Target $495.0
● Now $527.07 ● Target $443.5
TRADING DATA
Avg Volume 370K
YTD Return -7.7%
Analyst Count 12
Consensus Hold
Upside to Target -15.9%
Last Updated 2026-06-27

ANALYST SUMMARY

Medpace Holdings, Inc. (MEDP) is currently trading at $527.07 with a Wall Street consensus price target of $443.5, which is 15.9% below the current price over the next 12 months. 12 analysts currently cover MEDP, with a consensus rating of Hold - 33% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $495.0, while the most cautious has a target of $329.0.

MEDP operates in the Healthcare sector with a market capitalisation of $15B. The stock is down 7.7% year-to-date and is currently trading near the upper end of its 52-week range of $306.7 – $628.92.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for MEDP, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Barclays — Reiterated
Equal-Weight → Equal-Weight 2026-04-24 Building track record
BMO Capital — Reiterated
Market Perform → Market Perform 2026-04-24 Building track record
RBC Capital — Reiterated
Outperform → Outperform 2026-04-24 Building track record
Baird — Reiterated
Outperform → Outperform 2026-04-24 Building track record
Barclays ↑ Upgrade
Underweight → Equal-Weight 2026-03-06 Building track record
RBC Capital ● Initiated
Outperform 2026-03-03 Building track record
TD Cowen ↑ Upgrade
Sell → Hold 2026-02-18 Building track record
Jefferies ↑ Upgrade
Hold → Buy 2026-02-13 50% win rate (6 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
46
out of 100
Coverage depth
20/30
Consensus clarity
24/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →